Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma

Sci Adv. 2022 Dec 14;8(50):eabp8674. doi: 10.1126/sciadv.abp8674. Epub 2022 Dec 14.

Abstract

Studies to date have not resolved how diverse transcriptional programs contribute to the intratumoral heterogeneity of small cell lung carcinoma (SCLC), an aggressive tumor associated with a dismal prognosis. Here, we identify distinct and commutable transcriptional states that confer discrete functional attributes in individual SCLC tumors. We combine an integrative approach comprising the transcriptomes of 52,975 single cells, high-resolution measurement of cell state dynamics at the single-cell level, and functional and correlative studies using treatment naïve xenografts with associated clinical outcomes. We show that individual SCLC tumors contain distinctive proportions of stable cellular states that are governed by bidirectional cell state transitions. Using drugs that target the epigenome, we reconfigure tumor state composition in part by altering individual state transition rates. Our results reveal new insights into how single-cell transition behaviors promote cell state equilibrium in SCLC and suggest that facile plasticity underlies its resistance to therapy and lethality.

MeSH terms

  • Humans
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • Prognosis
  • Small Cell Lung Carcinoma* / genetics
  • Small Cell Lung Carcinoma* / pathology